![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Snell N.
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.6, Iss.8, 1997-08, pp. : 1001-1008
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
New Developments in the Treatment of Functional Dyspepsia
Drugs, Vol. 63, Iss. 9, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
New developments in the treatment of ovarian cancer
By Wadler Scott
Expert Opinion on Investigational Drugs, Vol. 10, Iss. 6, 2001-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacological Treatment of Fibromyalgia Syndrome: New Developments
By Staud Roland
Drugs, Vol. 70, Iss. 1, 2010-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
New Pharmacological Developments in the Treatment of Hepatocellular Cancer
Drugs, Vol. 69, Iss. 18, 2009-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Current Options and New Developments in the Treatment of Haemophilia
By Wong Trisha
Drugs, Vol. 71, Iss. 3, 2011-02 ,pp. :